About Theron Pharma
Theron Pharma is a company based in Sunnyvale (United States) founded in 2008. Theron Pharma has raised $2.21 million across 6 funding rounds from investors including HHS. Theron Pharma operates in a competitive market with competitors including Dren Bio, PureTech Health, Adagene, Innoviva and Landos Biopharma, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Theron Pharmaceuticals Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.21 M (USD)
in 6 rounds
-
Latest Funding Round
$409.1 K (USD), Seed
Jul 31, 2015
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Theron Pharma
Theron Pharma has successfully raised a total of $2.21M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $409.1 thousand completed in July 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Theron Pharma
Theron Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Theron Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Theron Pharma
Investment portfolio details for Theron Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Theron Pharma
Detailed financials for Theron Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Theron Pharma Comparisons
Peer comparison for Theron Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Theron Pharma
Theron Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dren Bio, PureTech Health, Adagene, Innoviva and Landos Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic antibodies are developed for cancer, autoimmune, and serious diseases.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Immunotherapy antibodies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Respiratory prescription drugs are developed and in-licensed for COPD treatment.
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for autoimmune diseases are developed.
|
|
| Locked | Locked | Locked |
Antibody-drug conjugates for cancer treatment are developed.
|
Detailed competitors of Theron Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Theron Pharma
Complete news archive for Theron Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theron Pharma
Theron Pharma was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Theron Pharma is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Theron Pharma is a funded company, having raised a total of $2.21M across 6 funding rounds to date.
Theron Pharma was founded in 2008 in Sunnyvale, United States, within the pharmaceutical sector. Long-acting M3 muscarinic antagonists are developed for treating chronic obstructive pulmonary disease and severe asthma. Focus is placed on a once-daily inhaled bronchodilator with properties enabling use across dry powder inhalers, metered-dose inhalers, and nebulizers, alongside compatibility for multi-drug formulations. Operations center on drug development for respiratory conditions.
Theron Pharma's top competitors include Dren Bio, PureTech Health and Adagene.
Theron Pharma has 1 investor. Key investors include HHS.